Goin, Dana E.
Abrahamsson, Dimitri
Wang, Miaomiao
Park, June-Soo
Sirota, Marina
Morello-Frosch, Rachel
DeMicco, Erin
Trowbridge, Jessica
August, Laura
O’Connell, Steven
Ladella, Subhashini
Zlatnik, Marya G.
Woodruff, Tracey J.
Article History
Received: 15 October 2021
Revised: 2 March 2022
Accepted: 7 March 2022
First Online: 21 April 2022
Competing interests
: SOC discloses a financial interest in MyExposome, Inc., a small business that is marketing products related to the research being reported. The other authors report no competing interests.
: The Fresno Biomonitoring Study and the Chemicals in Our Bodies-2 study protocols were approved by the Institutional Review Boards of the University of California, San Francisco, University of California, Berkeley, and Fresno Community Regional Medical Center (IRB number 17-23688).